tirzepatide injectable FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Most Successful Weight Loss Program. ᐅ Buy Mounjaro (Tirzepatide) Injection

01/16/24 FDA authorizes foreign importation of Bicillin L-A (penicillin G benzathine) FDA authorizes foreign importation of Bicillin L-A (penicillin G benzathine) 07/31/25 Leqvio (inclisiran) Expanded indication July 31, 2025 - Novartis announced the FDA approval of Leqvio (inclisiran), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH)

No method guarantees zero regain, but gradual tapering of medication combined with continued lifestyle changes offers the best chance for sustained weight management

You do not need to explain your medication to servers

Each pound reduces anesthesia time and improves recovery odds

All had Type 2 diabetes and took either a GLP-1 or a sodium-glucose cotransporter-2 inhibitor

92 The analysis showed no difference in all-cause mortality among those with baseline HF when compared to placebo (HR 1.05